Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

Allergan667 enrolled

Overview

This is a postmarketing surveillance study in Korea to evaluate the safety and effectiveness of BOTOX® for lateral canthal lines (crow's feet lines) with or without simultaneous glabellar lines.

Study Type

OBSERVATIONAL

Enrollment

667

Conditions

Lateral Canthal Lines Crow's Feet Lines

Interventions

Botulinum Toxin Type ABIOLOGICAL

Botulinum toxin Type A injected into crow's feet line areas per clinical practice.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subject and Investigator decision to treat crow's feet lines with Botox® Exclusion Criteria: * None

Locations (1)

Dr. Robbin Clinic

Gangnam-gu, Seoul, South Korea

Outcomes

Primary Outcomes

Number of Participants with Adverse Events

Time frame: Up to 3 months

Secondary Outcomes

Investigator's Assessment of Change in Appearance of Crow's Feet Lines on a 3-Point Scale

Time frame: Baseline, Up to 3 months

Subject's Assessment of Change in Appearance of Crow's Feet Lines on a 7-Point Scale

Time frame: Baseline, Up to 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.